Hossein Rahimi
Impact in
-
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- CRISPR and Genetic Engineering 4
- Advanced biosensing and bioanalysis techniques 3
- RNA Interference and Gene Delivery 2
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Hossein Danafar (8 shared papers)Hamed Nosrati (8 shared papers)Marziyeh Salehiabar (5 shared papers)Mohammadreza Ghaffarlou (5 shared papers)Murat Barsbay (5 shared papers)Saeed Kaboli (6 shared papers)Soodabeh Davaran (3 shared papers)Taras Kavetskyy (3 shared papers)
- Journals
- Nanomedicine (3 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (2 papers)Gene (1 paper)CNS & Neurological Disorders - Drug Targets (1 paper)Trials (1 paper)
- Partner nations
- IranTürkiyeUnited States
In The Last Decade
Hossein Rahimi
31 papers receiving 411 citations
Peers
Comparison fields: 5 of 83
- Infectious Diseases 100
- Business and International Management 9
- Biomaterials 51
- Biomedical Engineering 148
- Molecular Biology 192
Countries citing papers authored by Hossein Rahimi
This map shows the geographic impact of Hossein Rahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossein Rahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossein Rahimi more than expected).
Fields of papers citing papers by Hossein Rahimi
This network shows the impact of papers produced by Hossein Rahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossein Rahimi. The network helps show where Hossein Rahimi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hossein Rahimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 112 | |
| 2 | 2020 | 65 | |
| 3 | 2021 | 59 | |
| 4 | 2022 | 42 | |
| 5 | 2024 | 26 | |
| 6 | Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers. | 2013 | 21 |
| 7 | 2022 | 12 | |
| 8 | 2021 | 12 | |
| 9 | 2022 | 8 | |
| 10 | 2020 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 5 | |
| 13 | Cytogenetic Abnormalities with Interphase FISH Method and Clinical Manifestation in Chronic Lymphocytic Leukemia Patients in North-East of Iran. | 2017 | 5 |
| 14 | 2022 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2014 | 2 | |
| 19 | 2014 | 2 | |
| 20 | Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer. | 2016 | 2 |
About Hossein Rahimi
Hossein Rahimi is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 414 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers), CRISPR and Genetic Engineering (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), RNA Interference and Gene Delivery (2 papers), T-cell and Retrovirus Studies (2 papers), Plant chemical constituents analysis (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (100 citations), Business and International Management (9 citations), Biomaterials (51 citations), Biomedical Engineering (148 citations) and Molecular Biology (192 citations). Hossein Rahimi has collaborated with scholars based in Iran, Türkiye and United States. Frequent co-authors include Hossein Danafar, Hamed Nosrati, Marziyeh Salehiabar, Mohammadreza Ghaffarlou, Murat Barsbay, Saeed Kaboli, Soodabeh Davaran, Taras Kavetskyy, Ali Sharafi and João Conde. Their work appears in journals such as Nanomedicine, Naunyn-Schmiedeberg s Archives of Pharmacology, Gene, CNS & Neurological Disorders - Drug Targets and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.